At5g35370 Antibody

What is At5g35370 and why is it important in plant research?

At5g35370 is a gene in Arabidopsis thaliana (Mouse-ear cress) that encodes a receptor-like kinase protein known as AtRLK. This protein has been identified as playing a significant role in low nitrogen stress tolerance mechanisms. The gene and its corresponding protein have attracted considerable research interest due to their involvement in plant stress responses, particularly in nutrient-limited conditions. Understanding At5g35370 and having reliable antibodies against it allows researchers to investigate cellular signaling pathways involved in plant stress responses .

How is At5g35370 Antibody typically validated for research applications?

Validation of At5g35370 Antibody typically involves multiple complementary approaches to ensure specificity and reliability. Quantitative reverse transcription-PCR (qRT-PCR) is commonly used to detect the expression of AtRLK (AT5G35370) in wild-type and transgenic plants . Additionally, verification of protein-protein interactions involving AtRLK often employs techniques such as the yeast two-hybrid system and luciferase complementary imaging (LCI) assays. For antibody validation specifically, western blot analysis using appropriate positive and negative controls (such as knockout lines) is essential to confirm specificity. Given that approximately 50% of commercial antibodies fail to meet basic standards for characterization, rigorous validation is critical for ensuring reliable research outcomes .

What is the subcellular localization of AtRLK (At5g35370) and how can antibodies help determine this?

AtRLK (At5g35370) has been experimentally determined to localize to the plasma membrane of Arabidopsis cells. This localization has been verified through transient expression of fusion constructs such as 35S:AtRLK-GFP in Arabidopsis protoplasts, with observation via confocal laser scanning microscopy . When using At5g35370 Antibody for subcellular localization studies, immunofluorescence microscopy with appropriate controls is the preferred approach. The plasma membrane localization is significant as it suggests AtRLK functions in cell surface signaling, potentially in perceiving and responding to external stimuli such as nutrient availability. Proper antibody-based localization experiments should include membrane markers (such as mCherry-tagged membrane proteins) for co-localization confirmation .

How can At5g35370 Antibody be used to investigate protein-protein interactions in stress response pathways?

At5g35370 Antibody enables sophisticated investigation of protein-protein interactions through techniques such as co-immunoprecipitation (Co-IP) followed by mass spectrometry or western blotting. Research has demonstrated that AtRLK physically interacts with AtAVP1, a proton-pyrophosphatase involved in enhancing low nitrogen stress tolerance . To effectively employ At5g35370 Antibody for interaction studies, researchers should optimize immunoprecipitation conditions (buffer composition, salt concentration, detergent type/concentration) specific to membrane proteins like AtRLK. The experimental design should include appropriate controls such as IgG precipitations and reciprocal Co-IPs to validate interactions. Proximity ligation assays (PLA) using At5g35370 Antibody paired with antibodies against potential interacting partners can provide additional spatial confirmation of protein-protein interactions within intact cells .

What are the challenges in using At5g35370 Antibody for quantitative protein expression analysis across different stress conditions?

Quantitative analysis of AtRLK protein expression using At5g35370 Antibody presents several methodological challenges that require careful experimental design. First, membrane proteins like AtRLK often require specialized extraction protocols to ensure complete solubilization without degradation. Researchers must optimize extraction buffers containing appropriate detergents and protease inhibitors. Second, the dynamic range of AtRLK expression under different stress conditions (particularly low nitrogen stress, which has been shown to induce AtRLK expression) necessitates careful calibration of antibody concentration and incubation conditions .

For reliable quantification, researchers should:

• Establish a standard curve using purified recombinant AtRLK protein

• Include internal loading controls appropriate for the experimental conditions

• Validate antibody linear detection range for the expected protein concentrations

• Consider complementary approaches (such as qRT-PCR) to correlate protein and transcript levels

Additionally, given the estimated 50% failure rate of commercial antibodies to meet basic characterization standards, independent validation of antibody specificity under each experimental condition is essential for reliable quantitative analysis .

How can genetic manipulation of At5g35370 be verified using the corresponding antibody?

A comprehensive verification protocol should include:

• Western blot analysis of protein expression with appropriate loading controls

• Immunolocalization to confirm expected subcellular distribution

• Functional assays to verify phenotypic consequences of genetic manipulation

• qRT-PCR to correlate transcript and protein abundance

When verifying protein-protein interactions in genetically modified plants, techniques such as the luciferase complementary imaging assay can be paired with antibody-based approaches. Research has successfully employed this technique to verify interactions between AtAVP1 and AtRLK, showing strong luminescence signals in co-injection regions while negative controls showed no signal .

What controls should be included when using At5g35370 Antibody in various experimental applications?

Proper experimental controls are essential for reliable results when using At5g35370 Antibody. The selection of controls should be tailored to the specific experimental approach:

The lack of adequate controls contributes significantly to the reproducibility crisis in antibody-based research. An estimated 50% of commercial antibodies fail to meet basic characterization standards, making rigorous validation essential for any experimental application .

How can contradictory results when using At5g35370 Antibody be troubleshooted and resolved?

When faced with contradictory results using At5g35370 Antibody, a systematic troubleshooting approach is necessary:

• Antibody validation reassessment: Verify specificity using western blot on wild-type versus knockout samples. Consider epitope blocking experiments to confirm specificity.

• Experimental conditions optimization: For membrane proteins like AtRLK, extraction and detection conditions significantly impact results. Systematically test different:

  • Lysis buffers (varying detergent types/concentrations)

  • Incubation temperatures and times

  • Blocking agents (BSA vs. milk proteins)

  • Secondary antibody types and dilutions

• Cross-validation with orthogonal methods: Complement antibody-based detection with:

  • Mass spectrometry analysis

  • Transcript quantification by qRT-PCR

  • Functional assays based on known AtRLK activities

  • Alternative antibodies targeting different epitopes of AtRLK

• Biological variables consideration: AtRLK expression is induced by low nitrogen stress , so contradictory results might stem from unrecognized differences in growth conditions, plant developmental stage, or tissue sampling. Standardize these variables and document them meticulously.

• Technical replication and statistical analysis: Ensure sufficient technical and biological replicates, and apply appropriate statistical tests to determine if apparent contradictions are statistically significant.

When reporting contradictory results, researchers should transparently document all validation steps undertaken and consider the possibility that biological complexities, rather than technical failures, might explain the discrepancies .

What are the optimal fixation and permeabilization methods when using At5g35370 Antibody for immunolocalization studies?

Successful immunolocalization of AtRLK using At5g35370 Antibody requires careful optimization of fixation and permeabilization protocols to preserve both antigenicity and cellular architecture:

For Arabidopsis tissues:

• Fixation options:

  • 4% paraformaldehyde in PBS (pH 7.4) for 1-2 hours at room temperature preserves most epitopes while maintaining structural integrity

  • Ethanol:acetic acid (3:1) fixation may be superior for certain tissues but can affect membrane protein epitopes

  • Light aldehyde fixation (0.5-1% paraformaldehyde) with shorter incubation may be optimal for sensitive epitopes

• Permeabilization considerations:

  • For membrane proteins like AtRLK, overly harsh permeabilization can disrupt localization

  • 0.1-0.3% Triton X-100 for 10-15 minutes is typically sufficient

  • For recalcitrant tissues, consider enzymatic digestion with pectolyase/cellulase prior to antibody incubation

  • Non-ionic detergents are generally preferred over ionic detergents for plasma membrane proteins

• Antibody penetration optimization:

  • Extended incubation times (overnight at 4°C) at higher antibody dilutions often yield better signal-to-noise ratios

  • Vacuum infiltration of antibody solutions can improve penetration in intact tissues

  • For thick sections, consider vibratome sectioning prior to immunolabeling

• Signal detection:

  • For co-localization studies, use spectrally distinct fluorophores for dual labeling

  • Include appropriate controls labeled with each fluorophore combination to account for bleed-through

  • Use membrane markers (such as mCherry-tagged membrane proteins) to confirm plasma membrane localization, as demonstrated in previous research

These methodological considerations should be systematically tested and optimized for each specific tissue type and developmental stage being studied.

How might CRISPR/Cas9-mediated genome editing be verified using At5g35370 Antibody?

CRISPR/Cas9 editing of the At5g35370 gene requires comprehensive verification strategies using the corresponding antibody:

• Protein expression validation:

  • Western blot analysis using At5g35370 Antibody can confirm complete knockout or expression of truncated/modified proteins

  • Quantitative analysis can determine the efficiency of the edit at the protein level

  • Serial dilutions of wild-type samples can establish detection limits for residual protein in knockout lines

• Functional validation:

  • Immunoprecipitation followed by activity assays can confirm loss of kinase activity in modified variants

  • Pull-down experiments can verify disruption of known protein-protein interactions, such as with AtAVP1

  • Immunofluorescence can confirm altered localization of mutant proteins

• Off-target effect assessment:

  • Antibody-based proteomics approaches can help identify unintended effects on proteins with similar sequences

  • Comparison of the experimental phenotype with known RNAi knockdown phenotypes can highlight discrepancies suggesting off-target effects

• Rescue experiment design:

  • Complementation with wild-type or tagged At5g35370 variants can be verified by western blotting

  • Quantitative analysis can ensure physiological expression levels in rescue lines

  • Functional recovery can be assessed through protein-protein interaction assays

The combination of molecular, biochemical, and cellular approaches provides comprehensive validation of genome editing outcomes, with the At5g35370 Antibody serving as a critical tool throughout this verification process.

What emerging single-cell technologies can benefit from At5g35370 Antibody applications?

Single-cell technologies represent a frontier in plant biology research, and At5g35370 Antibody can enable several cutting-edge applications:

• Single-cell proteomics:

  • Mass cytometry (CyTOF) using metal-conjugated At5g35370 Antibody allows quantification of AtRLK in individual cells

  • This approach can reveal cell-to-cell variation in stress responses within tissues

  • Integration with other signaling markers can map complete response networks at single-cell resolution

• Spatial transcriptomics-proteomics integration:

  • Combining At5g35370 Antibody immunofluorescence with in situ RNA detection enables correlation of protein expression with transcript levels in tissue contexts

  • This integrated approach can reveal post-transcriptional regulation under stress conditions

  • Computational integration of these datasets allows modeling of regulatory networks

• Proximity labeling approaches:

  • At5g35370 Antibody can validate proximity labeling experiments (BioID, APEX) targeting the AtRLK interactome

  • This combination provides spatial context to interaction networks identified by mass spectrometry

  • Time-resolved proximity labeling can track dynamic changes in the AtRLK interaction network during stress responses

• Microfluidic antibody-based assays:

  • Droplet-based single-cell protein analysis using At5g35370 Antibody can quantify AtRLK in hundreds of individual protoplasts

  • This approach enables correlation of AtRLK levels with physiological parameters in large populations

  • Combinatorial analysis with small molecule treatments can map response pathways at unprecedented resolution

These emerging technologies promise to reveal previously inaccessible insights into the heterogeneity of stress responses at the cellular level, with At5g35370 Antibody serving as a critical enabling reagent .

What are the key considerations for ensuring reproducible research when using At5g35370 Antibody?

Ensuring reproducible research with At5g35370 Antibody requires attention to multiple factors throughout the experimental workflow:

• Antibody selection and validation:

  • Verify antibody specificity using appropriate controls (wild-type vs. knockout)

  • Document lot number, supplier, and validation data

  • Consider using recombinant antibodies or nanobodies for improved reproducibility

  • Remember that approximately 50% of commercial antibodies fail to meet basic standards for characterization

• Experimental design:

  • Include all necessary controls for each application

  • Standardize plant growth conditions, noting that AtRLK expression is induced by low nitrogen stress

  • Determine optimal antibody concentration through titration experiments

  • Establish quantitative standards for each assay type

• Data analysis and reporting:

  • Apply appropriate statistical methods with sufficient biological replicates

  • Report all methodological details, including antibody dilution, incubation conditions, and buffer compositions

  • Share original, unprocessed images and blots as supplementary material

  • Describe all validation steps undertaken for the specific application

• Resource sharing:

  • Deposit detailed protocols in repositories

  • Consider sharing validated antibody aliquots with collaborators

  • Document antibody performance in community resources

By adhering to these best practices, researchers can address the estimated $0.4–1.8 billion in annual financial losses attributed to poorly characterized antibodies and substantially improve the reliability of At5g35370 research findings .

How does the broader antibody validation crisis impact research on AtRLK and what solutions exist?

The antibody validation crisis has significant implications for AtRLK research, but several solutions are emerging:

The antibody validation crisis, where approximately 50% of commercial antibodies fail to meet basic standards for characterization, has profound implications for AtRLK research specifically and plant biology broadly . This crisis manifests in:

Emerging solutions include:

• Standardized validation protocols:

  • Application-specific validation requirements (western blot, IP, IF, ELISA)

  • Multi-laboratory validation networks for community-important antibodies

  • Validation databases that aggregate user experiences and validation data

• Alternative technologies:

  • Recombinant antibodies with defined sequences ensure reproducibility

  • CRISPR-engineered cell lines expressing tagged endogenous proteins

  • Aptamer-based detection systems as antibody alternatives

• Community resources and education:

  • Training in antibody validation for early-career researchers

  • Repositories of validated antibodies with extensive characterization data

  • Journal requirements for detailed antibody validation